drugset
Drugs / CBD/CBD-A
last change 3 days ago re-read 3 minutes ago

CBD/CBD-A

Developed for
neuropathy, painful · spinal cord injury
Investigated by
Consortium for Medical Marijuana Clinical Outcomes Research · University of Miami

Trials 1

today NCT05630235 · Ph 1/2
2026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT05630235 Jun 2025 → Sep 2026 overdue neuropathy, painful, spinal cord injury University of Miami Active not recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CBD/CBD-A ClinicalTrials.gov intervention name — accepted as the source's own label NCT05630235 ↗
Route Oral “administered a one-time dose of 204.6 mg of CBD/CBD-A orally” NCT05630235 ↗